Strengths

● The company's profit outlook over the next few years is a strong asset.

● The company's attractive earnings multiples are brought to light by a P/E ratio at 12.04 for the current year.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2022 fiscal year.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● The company does not generate enough profits, which is an alarming weak point.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● Over the past four months, analysts' average price target has been revised downwards significantly.